Aredia, Pamidronate Newswire

Aredia, Pamidronate Newswire

Comprehensive Real-Time News Feed for Aredia, Pamidronate (generic).

Results 1 - 7 of 7 in Aredia, Pamidronate (generic)

  1. Medical detectives tackle undiagnosed diseases at UABRead the original story w/Photo

    Feb 2, 2016 | Alabama Live

    Stephanie Smith is kneeling beside daughter, Mandalynn Smith, who is laying in a hospital bed at Children's Hospital of Alabama during an infusion of pamidronate, a drug in the bisphosphonate family, used to treat bone diseases, as part of UAB's Undiagnosed Diseases Program, 2015. Stephanie Smith's third child, Gage, was different from the start.


  2. What It's Like a to parent a child with brittle bonesRead the original story w/Photo

    Dec 1, 2015 | The Globe and Mail

    This is part of a series that looks at extraordinary experiences in personal health. Share yours at [email protected] .


  3. Adjuvant bisphosphonate treatment in early breast cancer:...Read the original story

    Nov 3, 2015 | CiteULike

    Bisphosphonates have profound effects on bone physiology, and could modify the process of metastasis. We undertook collaborative meta-analyses to clarify the risks and benefits of adjuvant bisphosphonate treatment in breast cancer.


  4. Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294) - Financial and Strategic SWOT Analysis ReviewRead the original story w/Photo

    Sep 21, 2015 |

    Fast Market Research recommends "Shenzhen Salubris Pharmaceuticals Co., Ltd. - Financial and Strategic SWOT Analysis Review" from GlobalData, now available Shenzhen Salubris Pharmaceuticals Co., Ltd. is a pharmaceutical company that research, develops, manufactures and distributes pharmaceutical and healthcare products. The company's Cardiovascular and other specialty products include allie medoxomil, injection bivalirudin, clopidogrel bisulfate tablets, benazepril hydrochloride tablets, pamidronate disodium injection and desloratadine tablets.


  5. Market Report, 'China Zoledronic Acid Market, 2010-2019', publishedRead the original story w/Photo

    Sep 8, 2015 |

    Malignancy with bone metastases is common in patients with advanced tumor like breast cancer, lung cancer, prostate cancer and multiple myeloma. Since patients with breast cancer or prostate cancer have relatively long median survival time, they still face the problem of treating bone metastases.


  6. Growing calls for Defence to act on toxic jet fuel health concernsRead the original story w/Photo

    Sep 2, 2015 | ABC News

    MARK COLVIN: A growing number of former and serving defence force personnel exposed to toxic jet fuel are calling on Defence and the Veteran's Affairs Department to review how they award compensation. There's growing scientific evidence that links fuel exposure to a range of blood cancers.


  7. Osteonecrosis of jaw risk highest for IV bisphosphonate useRead the original story w/Photo

    Aug 31, 2015 | PhysOrg Weblog

    The risk of osteonecrosis of the jaw is highest in association with intravenous bisphosphonate use, according to a study published online Aug. 19 in the Journal of Bone and Mineral Research . Xiaoyan Zhang, M.D., Ph.D., from the College of Pharmacy at the University of Florida in Orlando, and colleagues analyzed ONJ cases and associated drugs in the U.S. Food and Drug Administration's adverse event reporting system .